These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34069732)

  • 21. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.
    Pirruccello M; De Camilli P
    Trends Biochem Sci; 2012 Apr; 37(4):134-43. PubMed ID: 22381590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.
    Shrimpton AE; Hoopes RR; Knohl SJ; Hueber P; Reed AA; Christie PT; Igarashi T; Lee P; Lehman A; White C; Milford DV; Sanchez MR; Unwin R; Wrong OM; Thakker RV; Scheinman SJ
    Nephron Physiol; 2009; 112(2):p27-36. PubMed ID: 19390221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and function of the Lowe syndrome protein OCRL1.
    Lowe M
    Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oculocerebrorenal syndrome of Lowe: an update.
    Bökenkamp A; Ludwig M
    Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.
    Swan LE; Tomasini L; Pirruccello M; Lunardi J; De Camilli P
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3511-6. PubMed ID: 20133602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate.
    Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW
    J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review.
    Zhang Y; Deng L; Chen X; Hu Y; Chen Y; Chen K; Zhou J
    BMC Med Genomics; 2021 Sep; 14(1):219. PubMed ID: 34488756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts.
    Chen S; Lo CH; Liu Z; Wang Q; Ning K; Li T; Sun Y
    Hum Mol Genet; 2024 Jun; 33(13):1142-1151. PubMed ID: 38557732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal manifestations of Dent disease and Lowe syndrome.
    Cho HY; Lee BH; Choi HJ; Ha IS; Choi Y; Cheong HI
    Pediatr Nephrol; 2008 Feb; 23(2):243-9. PubMed ID: 18038239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.
    Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y
    J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.
    Hichri H; Rendu J; Monnier N; Coutton C; Dorseuil O; Poussou RV; Baujat G; Blanchard A; Nobili F; Ranchin B; Remesy M; Salomon R; Satre V; Lunardi J
    Hum Mutat; 2011 Apr; 32(4):379-88. PubMed ID: 21031565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
    Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
    CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations.
    Liu H; Barnes J; Pedrosa E; Herman NS; Salas F; Wang P; Zheng D; Lachman HM
    J Neurodev Disord; 2020 May; 12(1):14. PubMed ID: 32393163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Lowe syndrome protein OCRL1 is required for endocytosis in the zebrafish pronephric tubule.
    Oltrabella F; Pietka G; Ramirez IB; Mironov A; Starborg T; Drummond IA; Hinchliffe KA; Lowe M
    PLoS Genet; 2015 Apr; 11(4):e1005058. PubMed ID: 25838181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel OCRL1 mutations in patients with the phenotype of Dent disease.
    Utsch B; Bökenkamp A; Benz MR; Besbas N; Dötsch J; Franke I; Fründ S; Gok F; Hoppe B; Karle S; Kuwertz-Bröking E; Laube G; Neb M; Nuutinen M; Ozaltin F; Rascher W; Ring T; Tasic V; van Wijk JA; Ludwig M
    Am J Kidney Dis; 2006 Dec; 48(6):942.e1-14. PubMed ID: 17162149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
    Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
    Mol Autism; 2018; 9():44. PubMed ID: 30147856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding.
    McCrea HJ; Paradise S; Tomasini L; Addis M; Melis MA; De Matteis MA; De Camilli P
    Biochem Biophys Res Commun; 2008 May; 369(2):493-9. PubMed ID: 18307981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel OCRL mutations in Chinese children with Lowe syndrome.
    Zhang YQ; Wang F; Ding J; Yan H; Yang YL
    World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin.
    Vicinanza M; Di Campli A; Polishchuk E; Santoro M; Di Tullio G; Godi A; Levtchenko E; De Leo MG; Polishchuk R; Sandoval L; Marzolo MP; De Matteis MA
    EMBO J; 2011 Oct; 30(24):4970-85. PubMed ID: 21971085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.